| Challenges and achievements of promoting rational use of drugs in Iran F Soleymani, M Valadkhani, R Dinarvand Iranian Journal of Public Health 38 (1), 166-168, 2009 | 48 | 2009 |
| Ten years pharmacovigilance activities in Iran G Shalviri, M Valadkhani, R Dinarvand IRANIAN JOURNAL OF PUBLIC HEALTH 38 (1), 162-165, 2009 | 15 | 2009 |
| Current regulatory and scientific considerations for approving biosimilars in Iran N Hadavand, M Valadkhani, A Zarbakhsh Biologicals 39 (5), 325-327, 2011 | 11 | 2011 |
| Comparison of the Adjuvanticity of Aluminum Salts and Their Combination in Hepatitis B Recombinant Protein Vaccine Assessed in Mice A Mahboubi, MR Fazeli, R Dinavand, N Samadi, M Sharifzadeh, H Ilka, ... Iranian Journal of Immunology 5 (3), 163-170, 2008 | 5 | 2008 |
| Health Technology Assessment of Infliximab: A Rapid Review of Type 2 Studies. M Mobinizadeh, A Oliyaeemanesh, S Doaee, M Nejati, P Aboee, ... Journal of Isfahan Medical School 30 (178), 2012 | 2 | 2012 |
| Aluminum phosphate shows more adjuvanticity than Aluminum hydroxide in recombinant hepatitis–B vaccine formulation MR Fazeli, R Dinarvand, N Samadi, A Mahboubi, H Ilka, M Sharifzadeh, ... DARU JOURNAL OF PHARMACEUTICAL SCIENCE 16 (3), 143-148, 2008 | 2 | 2008 |
| Comparison of immunogenicity in Balb/C mice of commercially available recombinant hepatitis B vaccines in Iran. A Mahboubi, TH Shooshtari, MR Fazeli, R Dinarvand, N Samadi, ... | 1 | 2008 |
| Assessment of different bioequivalent metrics in Rifampin bioequivalence study MR Rouini, H Tajerzadeh, M Valadkhani DARU JOURNAL OF PHARMACEUTICAL SCIENCE 10 (2), 54-57, 2002 | 1 | 2002 |
| Dispersion model of hepatic elimination: studies on diclofenac in hepatic cirrhosis H Tajerzadeh, MR Rouini, M Valadkhani J. Pharm. Pharmacol, 54, 2002 | | 2002 |
| Podium Presentation VIII.(BPK/PD): Investigation of in vitro/in vivo correlation of rifampin capsules MR Rouini, M Valadkhani, H Tajerzadeh ACTA PHARMACEUTICA TURCICA 42, 32-32, 2000 | | 2000 |
| Determination of rifampin and deacetylrifampin in human urine using HPLC method M Valadkhani, H Tajerzadeh, MR Rouini ACTA PHARMACEUTICA TURCICA 42, 114-114, 2000 | | 2000 |
| Is USP dissolution medium capable of predicting the bioavailability of rifampin capsules? MR Rouini, H Tajerzadeh, M Valadkhani JOURNAL OF PHARMACY AND PHARMACOLOGY 52 (9; SUPP/1), 191-191, 2000 | | 2000 |
| Comparison of adjuvanticity of aluminum salts and their combination in Hepatitis B recombinant protein vaccine in mice A Mahboubi, MR Fazeli, R Dinarvand, N Samadi, M Sharifzadeh, H Ilka, ... | | |
